{"organizations": [], "uuid": "78d4f5ec3aecf470d681a642b7fecb59118b9885", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/03/20/the-associated-press-arcadia-biosciences-reports-4q-loss.html", "country": "US", "domain_rank": 767, "title": "Arcadia Biosciences reports 4Q loss", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-20T23:41:00.000+02:00", "replies_count": 0, "uuid": "78d4f5ec3aecf470d681a642b7fecb59118b9885"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/03/20/the-associated-press-arcadia-biosciences-reports-4q-loss.html", "ord_in_thread": 0, "title": "Arcadia Biosciences reports 4Q loss", "locations": [], "entities": {"persons": [{"name": "davis", "sentiment": "none"}], "locations": [{"name": "calif.", "sentiment": "none"}, {"name": "davis", "sentiment": "none"}], "organizations": [{"name": "arcadia biosciences inc.", "sentiment": "negative"}, {"name": "rkda", "sentiment": "negative"}, {"name": "arcadia biosciences", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "DAVIS, Calif. (AP) _ Arcadia Biosciences Inc. (RKDA) on Tuesday reported a loss of $3 million in its fourth quarter.\nOn a per-share basis, the Davis, California-based company said it had a loss of $1.39.\nThe agricultural biotechnology trait company posted revenue of $1.4 million in the period.\nFor the year, the company reported that its loss narrowed to $15.7 million, or $7.28 per share. Revenue was reported as $4 million.\nArcadia Biosciences shares have climbed sevenfold since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $38.61, more than doubling in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on RKDA at https://www.zacks.com/ap/RKDA", "external_links": [], "published": "2018-03-20T23:41:00.000+02:00", "crawled": "2018-03-21T00:41:06.017+02:00", "highlightTitle": ""}